Biomimicking Polysaccharide Nanofibers Promote Vascular Phenotypes: A Potential Application for Vascular Tissue Engineering

The potential of electrospun pullulan/dextran (P/D) nanofibers (average diameter = 323 nm) for vascular tissue engineering applications is explored. The mechanical properties of the nanofibers are of the same order of magnitude as that of human arteries (Young's modulus ≈0.88 MPa; tensile stren...

Full description

Saved in:
Bibliographic Details
Published in:Macromolecular bioscience Vol. 12; no. 3; pp. 395 - 401
Main Authors: Shi, Liya, Aid, Rachida, Le Visage, Catherine, Chew, Sing Yian
Format: Journal Article
Language:English
Published: Weinheim WILEY-VCH Verlag 01-03-2012
WILEY‐VCH Verlag
Wiley-VCH
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The potential of electrospun pullulan/dextran (P/D) nanofibers (average diameter = 323 nm) for vascular tissue engineering applications is explored. The mechanical properties of the nanofibers are of the same order of magnitude as that of human arteries (Young's modulus ≈0.88 MPa; tensile strength ≈0.35 MPa). It is demonstrated that the nanofiber topography enables cell adhesion and that the endothelial phenotype is maintained on the nanofibers. Moreover, P/D nanofibers support a stable confluent monolayer of endothelial cells over 14 d. SMCs seeded on nanofibers display similar levels of alpha smooth muscle actin and a lower proliferation rate than cells on 2D cultures. The observations suggest that nanofibers promote a shift to a quiescent contractile phenotype in SMCs. The efficacy of pullulan/dextran nanofibers for vascular tissue engineering is studied. P/D nanofiber topography enables EC and SMC attachment. The endothelial phenotype is maintained for at least 14 d. P/D nanofibers support a stable confluent layer of ECs, and the morphology in SMCs suggests that nanofibers promote a shift to a quiescent contractile phenotype.
Bibliography:ArticleID:MABI201100336
istex:102A6DB5708E5D8840CA2AB245C890E6B17A6513
National Medical Research Council (NMRC) Exploratory/Development - No. (NMRC/EDG/0027/2008)
ark:/67375/WNG-5SFXQK8B-S
Inserm, University Paris 7, University Paris 13 (Office of International Programs)
MOE Tier 1 Research - No. RG36/07; No. RG75/10
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1616-5187
1616-5195
DOI:10.1002/mabi.201100336